No Data
No Data
SoftBank Adds to Shares in VTEX, YMM, Cuts NMRA and Exits DASH, Among Other Moves
SoftBank Group 13F Update: New 14.67M Share Stake In Recursion Pharmaceuticals, 20.45M Shares In Pacific Biosciences, 628.55K Shares In Better Home & Finance; Dissolved 5.68M Shares Stake In Exscientia, 1.59M Shares In IonQ, 23.38K Shares In DoorDash;...
Neumora Therapeutics Price Target Maintained With a $30.00/Share by HC Wainwright & Co.
Neumora Therapeutics Analyst Ratings
Positive Prospects for Neumora Therapeutics: Buy Rating Supported by Leadership Change and Strategic R&D Focus
Neumora Therapeutics Names Paul Berns as CEO, Michael Milligan as CFO